Kalbe Farma Company Insiders
| PTKFY Stock | USD 21.05 0.00 0.00% |
Kalbe Farma employs about 12.6 K people. The company is managed by 18 executives with a total tenure of roughly 157 years, averaging almost 8.0 years of service per executive, having 702.44 employees per reported executive. Break down of Kalbe Farma's management performance can provide insight into the company performance.
| Johannes Setijono President President Commissioner |
| Bernadette Setiady President President Director |
Kalbe |
Kalbe Farma Management Team Effectiveness
The company has return on total asset (ROA) of 0.106 % which means that it generated a profit of $0.106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1673 %, meaning that it generated $0.1673 on every $100 dollars invested by stockholders. Kalbe Farma's management efficiency ratios could be used to measure how well Kalbe Farma manages its routine affairs as well as how well it operates its assets and liabilities.Kalbe Farma Workforce Comparison
Kalbe Farma Tbk is considered to be number one stock in number of employees category among related companies. The total workforce of Drug Manufacturers—General industry is at this time estimated at about 273,613. Kalbe Farma holds roughly 12,644 in number of employees claiming about 5% of equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Kalbe Farma Tbk Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Kalbe Farma Tbk Price Series Summation is a cross summation of Kalbe Farma price series and its benchmark/peer.
Kalbe Farma Notable Stakeholders
A Kalbe Farma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Kalbe Farma often face trade-offs trying to please all of them. Kalbe Farma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Kalbe Farma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Johannes Setijono | President Commissioner | Profile | |
| Bernadette Setiady | President Director | Profile | |
| Djonny Tjahyadi | Director | Profile | |
| Ongkie Tedjasurja | Director | Profile | |
| Bernadus Winata | Independent Director, Corporate Secretary | Profile | |
| Bujung Nugroho | Director | Profile | |
| Bapak Vidjongtius | Corporate Secretary, Independent Director, Member of Bus. Risk Committee and Member of Good Corporate Governance Committee | Profile | |
| Lanny Soputro | G HR | Profile | |
| Ferdinand Aryanto | Commissioner | Profile | |
| Santoso Oen | Commissioner | Profile | |
| Sie Djohan | Management Devel | Profile | |
| Lucky Slamet | Independent Commissioner | Profile | |
| Farid Moeloek | Independent Commissioner | Profile | |
| Kurniawan Suhartono | Head Unit | Profile | |
| Lilis Halim | Independent Commissioner | Profile | |
| Johanes Ibrahim | Independent Commissioner | Profile | |
| Ronny Hadiana | Commissioner | Profile | |
| Lukito Gozali | Head Relations | Profile |
About Kalbe Farma Management Performance
The success or failure of an entity such as Kalbe Farma Tbk often depends on how effective the management is. Kalbe Farma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Kalbe management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Kalbe management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia. Pt Kalbe operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 12501 people.
The data published in Kalbe Farma's official financial statements usually reflect Kalbe Farma's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Kalbe Farma Tbk. For example, before you start analyzing numbers published by Kalbe accountants, it's critical to develop an understanding of what Kalbe Farma's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Kalbe Farma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kalbe Farma's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Kalbe Farma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Kalbe Farma Tbk. Please utilize our Beneish M Score to check the likelihood of Kalbe Farma's management manipulating its earnings.
Kalbe Farma Workforce Analysis
Traditionally, organizations such as Kalbe Farma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Kalbe Farma within its industry.Kalbe Farma Manpower Efficiency
Return on Kalbe Farma Manpower
| Revenue Per Employee | 2.1B | |
| Revenue Per Executive | 1.5T | |
| Net Income Per Employee | 251.8M | |
| Net Income Per Executive | 176.9B |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Kalbe Farma Tbk. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Kalbe Farma Tbk information on this page should be used as a complementary analysis to other Kalbe Farma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Kalbe Pink Sheet analysis
When running Kalbe Farma's price analysis, check to measure Kalbe Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalbe Farma is operating at the current time. Most of Kalbe Farma's value examination focuses on studying past and present price action to predict the probability of Kalbe Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalbe Farma's price. Additionally, you may evaluate how the addition of Kalbe Farma to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |